Ollin Biosciences is a Biotech company based in Austin, Texas. It has raised $330M in total funding. Latest round: Series B.
Ollin Biosciences is a Biotech company based in Austin, Texas. Ollin Biosciences has raised $330M in total disclosed funding. That places its disclosed total in the $250M–$1B range. Its most recent disclosed round is a Series B announced in June 2026. The round record for Ollin Biosciences runs through 2026; nothing later has been disclosed. Investors on record include ARCH Venture Partners, Mubadala Capital, Monograph Capital, Wellington Management, TCGX, J.P. Morgan Life Sciences Private Capital and 3 others. 9 distinct backers are named across the disclosed rounds.
We update the Ollin Biosciences record whenever a new round is filed or announced, so the totals above track the public record rather than estimates. Related Biotech companies in Austin and their backers are listed below.
Company funding database · Investor directory · Founder database · Mega-rounds 2026